These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 26735340)

  • 21. Breast cancer detection using targeted plasma metabolomics.
    Jasbi P; Wang D; Cheng SL; Fei Q; Cui JY; Liu L; Wei Y; Raftery D; Gu H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jan; 1105():26-37. PubMed ID: 30562627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of bile biomarkers of biliary tract cancer through a liquid chromatography/mass spectrometry-based metabolomic method.
    Xu X; Cheng S; Ding C; Lv Z; Chen D; Wu J; Zheng S
    Mol Med Rep; 2015 Mar; 11(3):2191-8. PubMed ID: 25405977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Integrated analysis of serum untargeted metabolomics and targeted bile acid metabolomics for identification of diagnostic biomarkers for colorectal cancer].
    Wang X; Zhu Y; Zhou H; Huang Z; Chen H; Zhang J; Yang S; Chen G; Zhang Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Mar; 43(3):443-453. PubMed ID: 37087590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum peptide signatures for pancreatic cancer based on mass spectrometry: a comparison to CA19-9 levels and routine imaging techniques.
    Velstra B; Vonk MA; Bonsing BA; Mertens BJ; Nicolardi S; Huijbers A; Vasen H; Deelder AM; Mesker WE; van der Burgt YE; Tollenaar RA
    J Cancer Res Clin Oncol; 2015 Mar; 141(3):531-41. PubMed ID: 25240825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic profiling reveals new serum biomarkers for differentiating diabetic nephropathy.
    Hirayama A; Nakashima E; Sugimoto M; Akiyama S; Sato W; Maruyama S; Matsuo S; Tomita M; Yuzawa Y; Soga T
    Anal Bioanal Chem; 2012 Dec; 404(10):3101-9. PubMed ID: 23052862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pancreatic cancer screening using a multiplatform human serum metabolomics system.
    Sakai A; Suzuki M; Kobayashi T; Nishiumi S; Yamanaka K; Hirata Y; Nakagawa T; Azuma T; Yoshida M
    Biomark Med; 2016 Jun; 10(6):577-86. PubMed ID: 27171159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of metabolic biomarkers to diagnose epithelial ovarian cancer using a UPLC/QTOF/MS platform.
    Fan L; Zhang W; Yin M; Zhang T; Wu X; Zhang H; Sun M; Li Z; Hou Y; Zhou X; Lou G; Li K
    Acta Oncol; 2012 Apr; 51(4):473-9. PubMed ID: 22283470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolomics approaches in pancreatic adenocarcinoma: tumor metabolism profiling predicts clinical outcome of patients.
    Battini S; Faitot F; Imperiale A; Cicek AE; Heimburger C; Averous G; Bachellier P; Namer IJ
    BMC Med; 2017 Mar; 15(1):56. PubMed ID: 28298227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An NMR metabolomics approach for the diagnosis of leptomeningeal carcinomatosis in lung adenocarcinoma cancer patients.
    An YJ; Cho HR; Kim TM; Keam B; Kim JW; Wen H; Park CK; Lee SH; Im SA; Kim JE; Choi SH; Park S
    Int J Cancer; 2015 Jan; 136(1):162-71. PubMed ID: 24798643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolomic Profiling of Mice Serum during Toxoplasmosis Progression Using Liquid Chromatography-Mass Spectrometry.
    Zhou CX; Zhou DH; Elsheikha HM; Zhao Y; Suo X; Zhu XQ
    Sci Rep; 2016 Jan; 6():19557. PubMed ID: 26785939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colorectal cancer detection using targeted serum metabolic profiling.
    Zhu J; Djukovic D; Deng L; Gu H; Himmati F; Chiorean EG; Raftery D
    J Proteome Res; 2014 Sep; 13(9):4120-30. PubMed ID: 25126899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Gastroenterological Cancer Diagnosis by Metabolomics-Discovery of Pancreatic Cancer Biomarker].
    Yoshida M; Nishiumi S; Azuma T
    Rinsho Byori; 2015 Apr; 63(4):450-6. PubMed ID: 26536778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolomics discloses potential biomarkers for the noninvasive diagnosis of idiopathic portal hypertension.
    Seijo S; Lozano JJ; Alonso C; Reverter E; Miquel R; Abraldes JG; Martinez-Chantar ML; Garcia-Criado A; Berzigotti A; Castro A; Mato JM; Bosch J; Garcia-Pagan JC
    Am J Gastroenterol; 2013 Jun; 108(6):926-32. PubMed ID: 23419380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urinary metabolomics for discovering metabolic biomarkers of laryngeal cancer using UPLC-QTOF/MS.
    Chen J; Hou H; Chen H; Luo Y; Zhang L; Zhang Y; Liu H; Zhang F; Liu Y; Wang A; Hu Q
    J Pharm Biomed Anal; 2019 Apr; 167():83-89. PubMed ID: 30759408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The metabolic time line of pancreatic cancer: Opportunities to improve early detection of adenocarcinoma.
    Moore HB; Culp-Hill R; Reisz JA; Lawson PJ; Sauaia A; Schulick RD; Del Chiaro M; Nydam TL; Moore EE; Hansen KC; D'Alessandro A
    Am J Surg; 2019 Dec; 218(6):1206-1212. PubMed ID: 31514959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma metabolomic profile associated with fatigue in cancer patients.
    Feng LR; Barb JJ; Regan J; Saligan LN
    Cancer Med; 2021 Mar; 10(5):1623-1633. PubMed ID: 33534943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolite Analysis and Histology on the Exact Same Tissue: Comprehensive Metabolomic Profiling and Metabolic Classification of Prostate Cancer.
    Huan T; Troyer DA; Li L
    Sci Rep; 2016 Aug; 6():32272. PubMed ID: 27578275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer.
    Han SX; Zhou X; Sui X; He CC; Cai MJ; Ma JL; Zhang YY; Zhou CY; Ma CX; Varela-Ramirez A; Zhu Q
    Oncotarget; 2015 Aug; 6(23):19907-17. PubMed ID: 26101916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolomic-based biomarker discovery for non-invasive lung cancer screening: A case study.
    O'Shea K; Cameron SJ; Lewis KE; Lu C; Mur LA
    Biochim Biophys Acta; 2016 Nov; 1860(11 Pt B):2682-7. PubMed ID: 27423423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolomic study for diagnostic model of oesophageal cancer using gas chromatography/mass spectrometry.
    Wu H; Xue R; Lu C; Deng C; Liu T; Zeng H; Wang Q; Shen X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3111-7. PubMed ID: 19716777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.